Maternal obesity linked to 64% increase in childhood obesity risk
The roots of childhood obesity may begin in the womb. New research led by the George Mason University College of Public Health found that children whose mothers entered pregnancy with…
Understanding the benefits of GLP-1 drugs beyond obesity
In a Perspective, Daniel Drucker highlights the growing body of evidence that hints at the potential of glucagon-like peptide-1 (GLP-1)-based medications in treating conditions other than diabetes and obesity, including…
Two plant extracts with potential as GLP-1 agonist weight loss pills are identified by AI-based analysis
Two plant compounds with potential as GLP-1 agonist weight loss pills have been identified in an AI (artificial intelligence)-based study, the European Congress on Obesity (ECO 2024) (Venice 12-15 May),…